Off-Label Use of Intravenous Immunoglobulin with Methylprednisolone to Treat Parsonage–Turner Syndrome in a United States Marine

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td class="align_left"><object data="https://static-preview.hindawi.com/articles/crim/volume-2021/6663755/figures/6663755.tab-inline.003.svgz" name="6663755.tab-inline.003" type="image/svg+xml"></object></td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Summary of nerve conduction findings of the right limb at the time of diagnosis (pretreatment, gray shading) compared to 3.5 years, posttreatment with IVIG (posttreatment, green shading).<br/></div></td></tr></table>

<div>Nerve conduction findings of right limb.</div>

Case Reports in Medicine

tab3

Table 3

Table 3: Off-Label Use of Intravenous Immunoglobulin with Methylprednisolone to Treat Parsonage–Turner Syndrome in a United States Marine 